Literature DB >> 22866208

Bicyclic Cyclohexenones as Inhibitors of NF-κB Signaling.

Joseph K Hexum1, Rodolfo Tello-Aburto, Nicholas B Struntz, Andrew M Harned, Daniel A Harki.   

Abstract

A series of structurally simplified cryptocaryone analogues were synthesized by a facile Pd-catalyzed acetoxylation of alkyne-tethered cyclohexadienones and evaluated as inhibitors of NF-κB signaling. Compounds 10 and 11 were found to possess low micromolar inhibitory properties towards induced NF-κB activity by blocking p50/p65 nuclear protein through a covalent inhibition mechanism. Both compounds were able to inhibit NF-κB-induced IL-8 expression and exhibited antiproliferative activity against two model cancer cell lines. These analogues constitute a promising new scaffold for the development of novel NF-κB inhibitors and anticancer agents.

Entities:  

Year:  2012        PMID: 22866208      PMCID: PMC3409840          DOI: 10.1021/ml300034a

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  32 in total

1.  Cryptocaryone, a natural dihydrochalcone, induces apoptosis in human androgen independent prostate cancer cells by death receptor clustering in lipid raft and nonraft compartments.

Authors:  Yi-Cheng Chen; Fan-Lu Kung; Ian-Lih Tsai; Tsung-Hsien Chou; Ih-Sheng Chen; Jih-Hwa Guh
Journal:  J Urol       Date:  2010-04-18       Impact factor: 7.450

Review 2.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

Review 3.  The resurgence of covalent drugs.

Authors:  Juswinder Singh; Russell C Petter; Thomas A Baillie; Adrian Whitty
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

Review 4.  Return to homeostasis: downregulation of NF-κB responses.

Authors:  Jürgen Ruland
Journal:  Nat Immunol       Date:  2011-06-19       Impact factor: 25.606

Review 5.  Perspectives on sesquiterpene lactones in inflammation and cancer.

Authors:  Irmgard Merfort
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

Review 6.  Interleukin-8 and human cancer biology.

Authors:  K Xie
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

7.  Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity.

Authors:  Garrett C Moraski; Lowell D Markley; Philip A Hipskind; Helena Boshoff; Sanghyun Cho; Scott G Franzblau; Marvin J Miller
Journal:  ACS Med Chem Lett       Date:  2011-06-09       Impact factor: 4.345

8.  Palladium-catalyzed reactions of cyclohexadienones: regioselective cyclizations triggered by alkyne acetoxylation.

Authors:  Rodolfo Tello-Aburto; Andrew M Harned
Journal:  Org Lett       Date:  2009-09-03       Impact factor: 6.005

9.  Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosa.

Authors:  Tamara L Meragelman; Dominic A Scudiero; R Eric Davis; Louis M Staudt; Thomas G McCloud; John H Cardellina; Robert H Shoemaker
Journal:  J Nat Prod       Date:  2009-03-27       Impact factor: 4.050

Review 10.  NF-kappaB and cancer-identifying targets and mechanisms.

Authors:  Willscott E Naugler; Michael Karin
Journal:  Curr Opin Genet Dev       Date:  2008-04-24       Impact factor: 5.578

View more
  12 in total

1.  Targeting NF-κB p65 with a Helenalin Inspired Bis-electrophile.

Authors:  John C Widen; Aaron M Kempema; Peter W Villalta; Daniel A Harki
Journal:  ACS Chem Biol       Date:  2016-11-28       Impact factor: 5.100

2.  Recognition of nucleic acid junctions using triptycene-based molecules.

Authors:  Stephanie A Barros; David M Chenoweth
Journal:  Angew Chem Int Ed Engl       Date:  2014-09-24       Impact factor: 15.336

3.  Catch and Release DNA Decoys: Capture and Photochemical Dissociation of NF-κB Transcription Factors.

Authors:  Nicholas B Struntz; Daniel A Harki
Journal:  ACS Chem Biol       Date:  2016-04-07       Impact factor: 5.100

4.  Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.

Authors:  Paul A Jackson; John C Widen; Daniel A Harki; Kay M Brummond
Journal:  J Med Chem       Date:  2016-12-20       Impact factor: 7.446

5.  Synthesis and antileukemic activities of C1-C10-modified parthenolide analogues.

Authors:  Aaron M Kempema; John C Widen; Joseph K Hexum; Timothy E Andrews; Dan Wang; Susan K Rathe; Frederick A Meece; Klara E Noble; Zohar Sachs; David A Largaespada; Daniel A Harki
Journal:  Bioorg Med Chem       Date:  2015-05-30       Impact factor: 3.641

6.  A Chemical Strategy for Intracellular Arming of an Endogenous Broad-Spectrum Antiviral Nucleotide.

Authors:  Kellan T Passow; Haley S Caldwell; Kiet A Ngo; Jamie J Arnold; Nicole M Antczak; Anoop Narayanan; Joyce Jose; Shana J Sturla; Craig E Cameron; Alexander T Ciota; Daniel A Harki
Journal:  J Med Chem       Date:  2021-10-18       Impact factor: 7.446

7.  Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor.

Authors:  Anand Divakaran; Siva K Talluri; Alex M Ayoub; Neeraj K Mishra; Huarui Cui; John C Widen; Norbert Berndt; Jin-Yi Zhu; Angela S Carlson; Joseph J Topczewski; Ernst K Schonbrunn; Daniel A Harki; William C K Pomerantz
Journal:  J Med Chem       Date:  2018-10-16       Impact factor: 7.446

8.  A redox economical synthesis of bioactive 6,12-guaianolides.

Authors:  Bo Wen; Joseph K Hexum; John C Widen; Daniel A Harki; Kay M Brummond
Journal:  Org Lett       Date:  2013-05-10       Impact factor: 6.005

9.  Helenalin Analogues Targeting NF-κB p65: Thiol Reactivity and Cellular Potency Studies of Varied Electrophiles.

Authors:  John C Widen; Aaron M Kempema; Jordan W Baur; Hannah M Skopec; Jacob T Edwards; Tenley J Brown; Dennis A Brown; Frederick A Meece; Daniel A Harki
Journal:  ChemMedChem       Date:  2018-01-19       Impact factor: 3.466

10.  Synthesis of Guaianolide Analogues with a Tunable α-Methylene-γ-lactam Electrophile and Correlating Bioactivity with Thiol Reactivity.

Authors:  Paul A Jackson; Henry A M Schares; Katherine F M Jones; John C Widen; Daniel P Dempe; Francois Grillet; Matthew E Cuellar; Michael A Walters; Daniel A Harki; Kay M Brummond
Journal:  J Med Chem       Date:  2020-11-17       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.